Zepbound Without Insurance: Affordable Paths

Getting Zepbound without insurance

Without insurance, Zepbound retail prices can exceed $1086 per month — out of reach for most patients paying cash. But several alternative paths exist that can bring the monthly cost down dramatically. This page maps every option, with current verified pricing where available.

Option 1 — Telehealth partner subscriptions

Telehealth partner networks bundle the prescriber consultation, prescription, and dispensed medication into a flat monthly subscription. No insurance needed. The current lowest verified partner-network price for Zepbound is $329/month.

Option 2 — Manufacturer direct cash programs

Eli Lilly may offer a direct-to-consumer cash-pay program for Zepbound. Recent examples: LillyDirect (Eli Lilly's direct channel for Mounjaro and Zepbound at lower-than-retail pricing) and NovoCare Pharmacy (Novo Nordisk's direct channel for Wegovy and Ozempic). These programs typically:

• Don't require insurance
• Often require a valid prescription from any licensed US prescriber
• Ship medication directly to patient's home
• Are limited to certain doses (often early titration doses only)

Option 3 — Compounded versions

Compounded versions of the active ingredient in Zepbound (where available — typically semaglutide, tirzepatide, or liraglutide) are often significantly cheaper than the FDA-brand. However, compounded medications are not FDA-approved formulations. The FDA does not review compounded medications for safety, efficacy, or manufacturing quality. Key considerations:

• Following the FDA's 2025 declaration that the GLP-1 shortage is resolved, the legal basis for compounding has narrowed
• Quality varies by compounding pharmacy (state-licensed 503A or FDA-registered 503B)
• Adverse event reports for compounded GLP-1 have prompted FDA warnings
• Some compounded products contain added ingredients (B12, L-carnitine) to claim outside FDA restrictions — contested

See full compounded GLP-1 risk discussion in our medical disclaimer.

Option 4 — Patient assistance programs

Manufacturer patient assistance programs provide Zepbound at low or no cost for uninsured or underinsured patients meeting income criteria (typically ≤ 400% federal poverty level). Applications require documentation: tax returns, proof of denial from insurance, prescriber attestation. Apply for the Zepbound patient assistance program →

Option 5 — Discount cards (GoodRx, SingleCare)

Generic prescription discount cards from GoodRx, SingleCare, and Optum Perks may reduce retail pharmacy cash prices by 10-40%. These are universal — no insurance or prescription-specific application required. Savings on branded GLP-1s are typically modest compared to partner-network or compounded options.

What about Medicare and Medicaid?

If you have Medicare Part D or Medicaid, you have insurance — those programs may cover Zepbound under specific circumstances:

• Medicare Part D: Covers Zepbound for FDA-approved indications other than weight loss alone (e.g., type 2 diabetes for Ozempic, cardiovascular risk reduction for Wegovy). Coverage for weight loss alone is currently excluded by federal law — that may change.
• State Medicaid: Coverage varies widely. Roughly half of state Medicaid programs cover GLP-1s for weight loss; the other half do not. All cover for type 2 diabetes indication.

FAQ about Zepbound without insurance

See also: Zepbound full cost guide · Zepbound coupons · cheaper alternatives